Aida Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2007	FY 2006	FY 2005	FY 2004	FY 2003
Period Ending	Aug '25 Aug 4, 2025	Dec '07 Dec 31, 2007	Dec '06 Dec 31, 2006	Dec '05 Dec 31, 2005	Dec '04 Dec 31, 2004	Dec '03 Dec 31, 2003
Market Capitalization	0	31	49	46	-	-
Market Cap Growth	-53.37%	-37.22%	5.08%	-	-	-
Enterprise Value	-	61	80	60	-	-
Last Close Price	0.00	1.13	1.80	1.85	-	-
PE Ratio	-	11.14	33.44	31.50	-	-
PS Ratio	0.00	1.05	1.64	1.89	-	-
PB Ratio	0.00	1.44	3.15	4.50	-	-
P/TBV Ratio	-	7.11	62.39	14.54	-	-
P/FCF Ratio	0.00	6.99	54.12	9.02	-	-
P/OCF Ratio	0.00	3.64	18.27	7.56	-	-
EV/Sales Ratio	-	2.10	2.70	2.44	-	-
EV/EBITDA Ratio	-	8.30	13.26	15.67	-	-
EV/EBIT Ratio	-	11.29	20.30	28.18	-	-
EV/FCF Ratio	-	14.08	88.97	11.65	-	-
Debt / Equity Ratio	2.38	1.58	1.92	2.46	1.63	1.74
Debt / EBITDA Ratio	4.33	4.51	4.91	6.64	3.14	3.59
Debt / FCF Ratio	15.98	7.65	32.94	4.94	-	-
Asset Turnover	0.61	0.50	0.62	0.72	0.73	-
Inventory Turnover	3.66	4.11	4.34	2.58	1.61	-
Quick Ratio	0.46	0.74	0.68	0.48	0.51	0.59
Current Ratio	0.73	0.93	0.97	0.79	1.06	0.88
Return on Equity (ROE)	-1.79%	23.61%	16.71%	16.08%	40.93%	-
Return on Assets (ROA)	6.62%	5.84%	5.10%	3.90%	8.29%	-
Return on Capital (ROIC)	8.11%	6.83%	6.10%	4.98%	11.45%	-
Return on Capital Employed (ROCE)	23.70%	22.80%	17.00%	14.70%	36.00%	30.30%
Earnings Yield	-40343.13%	8.98%	2.99%	3.17%	-	-
FCF Yield	47701.11%	14.31%	1.85%	11.09%	-	-
Buyback Yield / Dilution	1.65%	-4.03%	-10.53%	-0.46%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.